CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma

CITN-06:一项针对晚期黑色素瘤患者的 I 期/扩展试验,评估 IL-15 超激动剂 alt-803 的疗效

阅读:1

Abstract

The goal of this work was to establish a reasonable baseline for research in patient cohort retrieval from clinical free text. Much recent work has used Lucene for this purpose. Our approach was to use MetaMap alone. We found that although many TREC 2011 Electronic Medical Records track participants found it difficult to beat a Lucene baseline, our MetaMap-based baseline did outperform a number of Lucene runs. We propose that MetaMap is a more valid baseline than Lucene, providing essential concept extraction, and that failure to make use of this industry-standard tool results in an unfairly low baseline for evaluation of system outputs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。